相关实验视频

Updated: Sep 19, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

微生物多组组分析揭示了与CD病因病理相关的新生物标志物和机制

Gerard Serrano-Gómez^1,2, Francisca Yañez¹, Zaida Soler^1,2

¹Microbiome Lab, Vall d'Hebron Institut de Recerca (VHIR), 119-129 pg Vall d'Hebron, Barcelona, 08035, Spain.

Biomarker research

|June 16, 2025

概括

这项研究揭示了克罗恩病 (CD) 肠道微生物组的特定特征,并确定了涉及大肠杆菌毒性因子的新机制. 这些发现提供了潜在的诊断生物标志物和对CD病变发生的洞察力.

科学领域:

微生物组研究的研究.
胃肠病学胃肠病学
免疫学免疫学免疫学

背景情况:

肠道微生物组失调与炎症性肠病 (IBD) 病原发生有关.
在IBD中的特定微生物贡献和机制仍然不太清楚.

研究的目的:

为了确定IBD的新型微生物组生物标志物.
阐明肠道微生物群在IBD发展中的机械作用.

主要方法:

多种omics方法包括枪头metagenomics,metatranscriptomics,以及便样本上的代谢学.
机器学习用于疾病预测和数据集成,以提出微生物机制.
分析了212个样本的元基因组学,103个元转录组学和105个代谢组学.

主要成果:

鉴定了20种克罗恩病 (CD) 的微生物群签名,具有高诊断性能 (AUC 0.94).
在CD中揭示了微生物发酵通路的改变和丁酸盐枯竭,但不是性结肠炎 (UC).
发现了大肠杆菌的毒性因素和新的机制,如阿斯巴酸盐的减少和酸的利用,导致CD的炎症.

结论:

该研究确定了IBD潜在的诊断生物标志物,特别是CD.
提供了关于克罗恩病微生物机制,炎症和毒性的一种综合的多学科观点.
突出了CD和UC之间独特的微生物机制,表明了亚型特定的IBD病原体.

关键词:

粘附性侵袭性大肠杆菌 (Escherichia coli) 是一种严重的疾病.炎症性肠病是一种炎症性肠病.微生物组是一个微生物组.多个omics的多个omics.病毒性基因病毒性基因

更多相关视频

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection

Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection

Published on: November 18, 2022

相关概念视频

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...